Plunkett Research Online: Amarin Corporation plc

AMARIN CORPORATION PLC (AMRN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Amarin Corporation plc is a pharmaceutical company focused on developing therapeutics to improve cardiovascular health. The firm’s platforms utilize the cardiovascular system’s innate quality of being affected by polyunsaturated fatty acids. Amarin’s lipophilic drugs are fat-soluble, allowing easy.....



Amarin Corporation plc
Ticker: AMRN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 353 1 6699 020
Fax:
Address: Upper Pembroke Street 28-32
2 Pembroke House
Dublin, 2 Ireland

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs, Cardiovascular
Drugs, Cardiovascular Health
Drugs, Triglyceride Reduction
ContactsDescription

John TheroCEO/Pres.
Michael W. KalbCFO
See More
Amarin Corporation plc is a pharmaceutical company focused on developing therapeutics to improve cardiovascular health. The firm’s platforms utilize the cardiovascular system’s innate quality of being affected by polyunsaturated fatty acids. Amarin’s lipophilic drugs are fat-soluble, allowing easy.....See More See More

Auditor: EY
Legal Advisor: K&L Gates LLP
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Vascepa
REDUCE-IT
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: